Cite
Pimozide augments bromocriptine lethality in prolactinoma cells and in a xenograft model via the STAT5/cyclin D1 and STAT5/Bcl‑xL signaling pathways.
MLA
Xiao, Zhengzheng, et al. “Pimozide Augments Bromocriptine Lethality in Prolactinoma Cells and in a Xenograft Model via the STAT5/Cyclin D1 and STAT5/Bcl‑xL Signaling Pathways.” International Journal of Molecular Medicine, vol. 47, no. 1, Jan. 2021, pp. 113–24. EBSCOhost, https://doi.org/10.3892/ijmm.2020.4784.
APA
Xiao, Z., Liang, J., Deng, Q., Song, C., Yang, X., Liu, Z., Shao, Z., Zhang, K., Wang, X., & Li, Z. (2021). Pimozide augments bromocriptine lethality in prolactinoma cells and in a xenograft model via the STAT5/cyclin D1 and STAT5/Bcl‑xL signaling pathways. International Journal of Molecular Medicine, 47(1), 113–124. https://doi.org/10.3892/ijmm.2020.4784
Chicago
Xiao, Zhengzheng, Jing Liang, Qing Deng, Chaojun Song, Xiaoli Yang, Zebin Liu, Zheng Shao, Kun Zhang, Xiaobin Wang, and Zhengwei Li. 2021. “Pimozide Augments Bromocriptine Lethality in Prolactinoma Cells and in a Xenograft Model via the STAT5/Cyclin D1 and STAT5/Bcl‑xL Signaling Pathways.” International Journal of Molecular Medicine 47 (1): 113–24. doi:10.3892/ijmm.2020.4784.